NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $7.72 million. The enterprise value is $4.61 million.
Important Dates
The last earnings date was Monday, October 6, 2025, before market open.
| Earnings Date | Oct 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NLSP has 4.15 million shares outstanding. The number of shares has increased by 201.68% in one year.
| Current Share Class | 3.16M |
| Shares Outstanding | 4.15M |
| Shares Change (YoY) | +201.68% |
| Shares Change (QoQ) | +96.52% |
| Owned by Insiders (%) | 25.07% |
| Owned by Institutions (%) | 8.50% |
| Float | 1.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.75 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.77
| Current Ratio | 2.77 |
| Quick Ratio | 2.50 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -53.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -75.98% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -116.63% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$887,719 |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.83% in the last 52 weeks. The beta is 0.13, so NLSP's price volatility has been lower than the market average.
| Beta (5Y) | 0.13 |
| 52-Week Price Change | -63.83% |
| 50-Day Moving Average | 2.15 |
| 200-Day Moving Average | 1.99 |
| Relative Strength Index (RSI) | 44.90 |
| Average Volume (20 Days) | 923,584 |
Short Selling Information
The latest short interest is 105,968, so 2.55% of the outstanding shares have been sold short.
| Short Interest | 105,968 |
| Short Previous Month | 21,500 |
| Short % of Shares Out | 2.55% |
| Short % of Float | 6.53% |
| Short Ratio (days to cover) | 0.55 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.36M |
| Pretax Income | -2.17M |
| Net Income | -6.21M |
| EBITDA | -3.36M |
| EBIT | -3.36M |
| Earnings Per Share (EPS) | -$2.06 |
Full Income StatementBalance Sheet
The company has $3.07 million in cash and n/a in debt, giving a net cash position of $3.07 million or $0.74 per share.
| Cash & Cash Equivalents | 3.07M |
| Total Debt | n/a |
| Net Cash | 3.07M |
| Net Cash Per Share | $0.74 |
| Equity (Book Value) | 2.88M |
| Book Value Per Share | 0.68 |
| Working Capital | 2.58M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.81 million and capital expenditures -$3,917, giving a free cash flow of -$4.82 million.
| Operating Cash Flow | -4.81M |
| Capital Expenditures | -3,917 |
| Free Cash Flow | -4.82M |
| FCF Per Share | -$1.16 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
